| Glial activation and inflammation along the Alzheimer’s disease continuum K Nordengen, BE Kirsebom, K Henjum, P Selnes, B Gísladóttir, ... Journal of neuroinflammation 16, 1-13, 2019 | 218 | 2019 |
| Detecting at-risk Alzheimer’s disease cases T Fladby, L Pålhaugen, P Selnes, G Bråthen, E Hessen, IS Almdahl, ... Journal of Alzheimer's Disease 60 (1), 97-105, 2017 | 60 | 2017 |
| Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease BE Kirsebom, K Nordengen, P Selnes, SB Torsetnes, B Gísladóttir, B Brix, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 4 …, 2018 | 34 | 2018 |
| Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years BE Kirsebom, R Espenes, E Hessen, K Waterloo, SH Johnsen, ... The Clinical Neuropsychologist 33 (sup1), 27-39, 2019 | 27 | 2019 |
| Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 years J Espenes, E Hessen, IV Eliassen, K Waterloo, M Eckerström, SB Sando, ... The Clinical Neuropsychologist 34 (sup1), 110-126, 2020 | 20 | 2020 |
| Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression N Siafarikas, BE Kirsebom, DP Srivastava, CM Eriksson, E Auning, ... Scientific Reports 11 (1), 20375, 2021 | 12 | 2021 |
| Regression-based norms for the FAS phonemic fluency test for ages 40–84 based on a Norwegian sample IM Lorentzen, J Espenes, E Hessen, K Waterloo, G Bråthen, S Timon, ... Applied Neuropsychology: Adult 30 (2), 159-168, 2023 | 11 | 2023 |
| Screening for Alzheimer’s disease: Cognitive impairment in self-referred and memory clinic-referred patients BE Kirsebom, R Espenes, E Hessen, SH Johnsen, G Bråthen, D Aarsland, ... Journal of Alzheimer's Disease 60 (4), 1621-1631, 2017 | 11 | 2017 |
| Exploration of plasma lipids in mild cognitive impairment due to Alzheimer’s disease AK Bergland, P Proitsi, BE Kirsebom, H Soennesyn, A Hye, AI Larsen, ... Journal of Alzheimer's Disease 77 (3), 1117-1127, 2020 | 9 | 2020 |
| Regression‐based normative data for the Rey Auditory Verbal Learning Test in Norwegian and Swedish adults aged 49–79 and comparison with published norms J Espenes, IV Eliassen, F Öhman, E Hessen, K Waterloo, M Eckerström, ... The Clinical Neuropsychologist 37 (6), 1276-1301, 2023 | 8 | 2023 |
| Amyloid plaques and symptoms of depression links to medical help-seeking due to subjective cognitive decline R Espenes, BE Kirsebom, C Eriksson, E Hessen, SH Johnsen, P Selnes, ... Journal of Alzheimer's Disease 75 (3), 879-890, 2020 | 8 | 2020 |
| Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer’s pathology and progression to dementia. IV Eliassen, T Fladby, BE Kirsebom, M Eckerström, A Wallin, G Bråthen, ... Neuropsychology 34 (8), 851, 2020 | 7 | 2020 |
| Timed up and go in people with subjective cognitive decline is associated with faster cognitive deterioration and cortical thickness MG Borda, D Ferreira, P Selnes, DA Tovar-Rios, A Jaramillo-Jiménez, ... Dementia and Geriatric Cognitive Disorders 51 (1), 63-72, 2022 | 5 | 2022 |
| In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with cerebrospinal fluid biomarkers for cognitive decline in contrast to the … E Hessen, BE Kirsebom, CM Eriksson, CF Eliassen, AE Nakling, ... Journal of Alzheimer's Disease 67 (2), 715-723, 2019 | 5 | 2019 |
| M üller KI, Nakling EA, Rongve A, Sando SB, Siafarikas N, Stav AL, Tecelao S, Timon S, Bekkelund SI, Aarsland D (2017) Detecting at-risk Alzheimer’s disease cases T Fladby, L Pålhaugen, P Selnes, K Waterloo, G Bråthen, E Hessen, ... J Alzheimers Dis 60, 97-105, 0 | 5 | |
| Medial temporal lobe atrophy in predementia Alzheimer’s disease: a longitudinal multi-site study comparing staging and A/T/N in a clinical research cohort JA Jarholm, A Bjørnerud, TO Dalaker, MS Akhavi, BE Kirsebom, ... Journal of Alzheimer's Disease, 1-21, 2023 | 3 | 2023 |
| The ANeED study–ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial LJ Chwiszczuk, MH Breitve, BEB Kirsebom, P Selnes, JC Fløvig, ... Frontiers in Aging Neuroscience 15, 1163184, 2023 | 2 | 2023 |
| Regression-based cognitive change norms applied in biochemically defined predementia Alzheimer’s disease. IV Eliassen, BE Kirsebom, T Fladby, SB Sando, MS Hemminghyth, ... Neuropsychology 37 (1), 32, 2023 | 2 | 2023 |
| Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer’s disease patients BE Kirsebom, G Richter, K Nordengen, D Aarsland, G Bråthen, BM Tijms, ... Brain Communications 4 (5), fcac244, 2022 | 1 | 2022 |
| Regression‐based normative data for the Rey Auditory Verbal Learning Test in Norwegian and Swedish adults ages 40 to 80: Neuropsychology/early detection of cognitive decline … J Espenes, IV Eliassen, T Fladby, M Eckerström, A Wallin, K Waterloo, ... Alzheimer's & Dementia 16, e044431, 2020 | 1 | 2020 |
